National · 2 sources
Why India rejected a patent application for shorter drug-resistant TB treatment | Explained
Coverage by lean
100% Lean Left0% Centre0% Right
Left 2
Centre 0
No coverage found on this side
Right 0
No coverage found on this side
One headline per side, the first Trikon holds. Every outlet is listed below.
Left · 2
The Hindu · Lean Left
Why India rejected a patent application for shorter drug-resistant TB treatment | Explained
◈ Kasturi & Sons Ltd, The Hindu Group
Hindustan Times · Lean Left
TB Alliance fails to get patent for six-month treatment regimen
◈ HT Media, K. K. Birla Group (Shobhana Bhartia)
Centre · 0
No coverage found on this side.
Right · 0
No coverage found on this side.
Verify with IFCN fact-checkers →FactlyIFCN ↗Quint WebQoofIFCN ↗Vishvas NewsIFCN ↗NewsCheckerIFCN ↗Google Fact Check ↗